Navigation Links
Chester County Biopharmaceutical Firm to Expand, Create 151 New Jobs
Date:9/10/2012

HARRISBURG, Pa., Sept. 10, 2012 /PRNewswire-USNewswire/ -- Governor Tom Corbett announced today that ViroPharma Inc. – a homegrown biopharmaceutical company – will expand its operations in Exton, Chester County and create 151 new, high-paying jobs. 

"ViroPharma is a true Pennsylvania success that continues to grow and create jobs in the region," said Corbett. "What started as a small team of entrepreneurs in Exton has now evolved into an international biopharmaceutical company employing hundreds of Pennsylvanians."

ViroPharma will nearly double its current available space by leasing an additional 71,000-square feet of office space to accommodate planned growth. The expansion will enable the company to retain its existing 188 employees and create at least 151 new jobs within three years.

The company received a $583,000 funding offer from the Department of Community and Economic Development, including a $130,000 Pennsylvania First grant and $453,000 in Job Creation Tax Credits.  

"For us it is about growth. ViroPharma has been in Exton for many years and we love our home here," said ViroPharma President and CEO Vincent J. Milano. "We're committed to this area for the long-term and look forward to creating opportunities in this community."

The project was coordinated by the Governor's Action Team, or GAT, economic development professionals who work directly with businesses that are considering locating or expanding in Pennsylvania. GAT worked with the Chester County Economic Development Council (CCEDC) to support ViroPharma's expansion.

"Chester County is fortunate to have companies like ViroPharma who continually innovate and reinvent themselves," said CCEDC President and CEO Gary Smith.  "Their expansion is the latest evidence that the life science community in Chester County is alive and well."

Founded in 1994 by a small team of entrepreneurial scientists in Exton, ViroPharma is focused on developing drugs for rare diseases in which there is an unmet medical need. The organization has grown into an international biopharmaceutical company with significant operations in Europe, in addition to Pennsylvania.

For more information about ViroPharma, visit www.viropharma.com.  

For more information on the Governor's Action Team and Pennsylvania's other economic development initiatives, visit www.newPA.com or call 1-866-466-3972.

Media contacts:

Kelli Roberts, Governor's Office; 717-783-1116
Theresa Elliott, DCED; 717-783-1132


'/>"/>
SOURCE Pennsylvania Office of the Governor
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Rochester Medical Reports Third Quarter Results
2. Rochester Medical Announces Third Quarter 2012 Earnings Conference Call Friday, July 27, 2012
3. Rochester Medical Introduces Magic3® Coude Tip Hydrophilic Intermittent Catheter
4. Saddleback Memorial Named First Robotic Training Epicenter for Gynecologic Surgery in Orange County
5. Governor Corbett: Lancaster County Commercial Lab to Expand, Create 200 New Jobs
6. National Press Club to Host "NEWSMAKER" with PhRMA CEO to Discuss Policy, Budget Threats to Biopharmaceutical Research
7. Alder Biopharmaceuticals Receives $3.5 Million Milestone Payment from Bristol-Myers Squibb for Initiation of Phase 2 Clinical Trial of ALD518/BMS-945429 in Crohns Disease
8. The Thousand-Year Business Model for a Modern Biopharmaceutical Company
9. Biopharmaceutical Service Providers Announce Collaborative Opening of Boston, MA Office
10. Keryx Biopharmaceuticals, Inc. To Host Conference Call on Second Quarter 2012 Financial Results
11. PAREXEL Launches The PAREXEL BioPharm Unit To Meet The Critical Development Goals Of Small And Mid-Sized Biopharmaceutical Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... /PRNewswire/ - Demers Ambulances announces its first delivery in the state ... County Emergency Medical Services (EMS) consisting of four ... van. Quality Emergency Vehicles in Lecanto, FL ... This is the latest in Demers, ongoing expansion of sales.  ... Demers. --> Benoit LaFortune , Executive Vice President ...
(Date:2/12/2016)... Feb. 12, 2016   HeartWare International, Inc . ... and webcast to discuss its financial results for the ... Thursday, February 25, 2016 at 8:00 a.m. ET.  The ... the conference call and webcast.  On the conference call ... highlights from the fourth quarter and business outlook.   ...
(Date:2/12/2016)... Kalifornien, 12. Februar 2016  Sequent Medical, Inc. ... von Patienten für eine Studie zur Sicherheit und ... speziell für die Behandlung von rupturierten intrakraniellen Aneurysmen ... Leiter der Neuroradiologie an der Universitätsklinik Bicètre in ... der CLARYS-Studie hat den ersten Patienten aufgenommen. ...
Breaking Medicine Technology:
(Date:2/13/2016)... ... ... With FCPX Overlay Embers from Pixel Film Studios users can now apply ... user can select from up to 40 effect overlays. With FCPX Overlay Embers users ... value, contrast, glow, and more all within a click of a mouse. , ...
(Date:2/13/2016)... , ... February 13, 2016 , ... ... of Nursing with an in-kind gift of a VeinViewer® Vision vein finder ... they learn how to start an IV and draw blood, combining technology with ...
(Date:2/13/2016)... (PRWEB) , ... February 13, 2016 , ... ... Tech Outlook’s top Clinical Data Management Solution Providers list for its expertise in ... functional and domain expertise to serve the technology needs of global clients. DDi ...
(Date:2/12/2016)... ... February 12, 2016 , ... The law firm of Morrow, Morrow, Ryan ... The purpose of these scholarships is to encourage applicants to pursue a degree in ... within these two parishes. , “We have available jobs in St. Landry and ...
(Date:2/12/2016)... Falls Church, VA (PRWEB) , ... February 12, 2016 , ... CDRH Enforcement Trends: , ... http://www.fdanews.com/cdrhenforcementtrends , As Winston Churchill said, “Those who don’t learn ... 2015 will show what to expect when they come knocking this year. But that takes ...
Breaking Medicine News(10 mins):